Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China
Author:
Affiliation:
1. Shanghai Public Health Clinical Center and Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, China
Publisher
American Medical Association (AMA)
Subject
Internal Medicine
Link
https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2769741/jamainternal_wu_2020_oi_200072_1601661089.65631.pdf
Reference20 articles.
1. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72?314 cases from the Chinese Center for Disease Control and Prevention.;Wu;JAMA,2020
2. On natural and artificial vaccinations.;Zinkernagel;Annu Rev Immunol,2003
3. Treatment of severe acute respiratory syndrome with convalescent plasma.;Wong;Hong Kong Med J,2003
4. Treatment with convalescent plasma for influenza A (H5N1) infection.;Zhou;N Engl J Med,2007
5. Evaluation of convalescent plasma for Ebola virus disease in Guinea.;van Griensven;N Engl J Med,2016
Cited by 203 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical data and quantitative CT parameters combined with machine learning to predict short-term prognosis of severe COVID-19 in the elderly;Heliyon;2024-09
2. Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination;iScience;2024-08
3. Teambuilding und Arbeitsplatzsicherheit während der ersten Welle der COVID-19-Pandemie;OP-Management up2date;2024-05
4. SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines;Journal of Medical Virology;2024-03
5. SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk;Journal of Perinatology;2023-12-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3